REQUEST A DEMO
Total
USD $0.00
Search more companies

Novo Pharma d.o.o. (Croatia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novo Pharma d.o.o. Profile Updated: July 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Novo Pharma d.o.o. is an enterprise based in Croatia. Its main office is in Zagreb. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on September 24, 2026. It currently has a total number of 2 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 93.53% in 2025. Its total assets grew by 66.55% over the same period. Novo Pharma d.o.o.’s net profit margin increased by 2.51% in 2025.

Headquarters
Poljana Borisa Hanzekovica 60 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Novo Pharma d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Novo Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Novo Pharma d.o.o. report to view the information.
Incorporation Date:
September 24, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novo Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
93.53%
Total Operating Revenue
93.53%
Operating Profit
182.11%
EBITDA
180.38%
Net Profit/Loss for the Period
182.08%
Total Assets
66.55%
Total Equity
164.56%
Operating Profit Margin
3.06%
Net Profit Margin
2.51%
Return on Equity (ROE)
5.98%
Quick Ratio
0.5%
Cash Ratio
0.51%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?